PYC Therapeutics Limited

ASX:PYC Stock Report

Market Cap: AU$863.2m

PYC Therapeutics Balance Sheet Health

Financial Health criteria checks 6/6

PYC Therapeutics has a total shareholder equity of A$81.1M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$91.2M and A$10.2M respectively.

Key information

0%

Debt to equity ratio

AU$0

Debt

Interest coverage ration/a
CashAU$66.87m
EquityAU$81.05m
Total liabilitiesAU$10.18m
Total assetsAU$91.24m

Recent financial health updates

Recent updates

We're Hopeful That PYC Therapeutics (ASX:PYC) Will Use Its Cash Wisely

Oct 25
We're Hopeful That PYC Therapeutics (ASX:PYC) Will Use Its Cash Wisely

Companies Like PYC Therapeutics (ASX:PYC) Are In A Position To Invest In Growth

Apr 10
Companies Like PYC Therapeutics (ASX:PYC) Are In A Position To Invest In Growth

Is PYC Therapeutics (ASX:PYC) In A Good Position To Deliver On Growth Plans?

Nov 10
Is PYC Therapeutics (ASX:PYC) In A Good Position To Deliver On Growth Plans?

We Think PYC Therapeutics (ASX:PYC) Needs To Drive Business Growth Carefully

Jul 03
We Think PYC Therapeutics (ASX:PYC) Needs To Drive Business Growth Carefully

Here's Why We're Watching PYC Therapeutics' (ASX:PYC) Cash Burn Situation

Jan 25
Here's Why We're Watching PYC Therapeutics' (ASX:PYC) Cash Burn Situation

Companies Like PYC Therapeutics (ASX:PYC) Are In A Position To Invest In Growth

Jul 31
Companies Like PYC Therapeutics (ASX:PYC) Are In A Position To Invest In Growth

We're Not Very Worried About PYC Therapeutics' (ASX:PYC) Cash Burn Rate

Mar 28
We're Not Very Worried About PYC Therapeutics' (ASX:PYC) Cash Burn Rate

Non-Executive Chair of the Board Alan Tribe Just Bought A Handful Of Shares In PYC Therapeutics Limited (ASX:PYC)

Feb 20
Non-Executive Chair of the Board Alan Tribe Just Bought A Handful Of Shares In PYC Therapeutics Limited (ASX:PYC)

Have Insiders Been Selling PYC Therapeutics Limited (ASX:PYC) Shares?

Jan 26
Have Insiders Been Selling PYC Therapeutics Limited (ASX:PYC) Shares?

What You Need To Know About PYC Therapeutics Limited's (ASX:PYC) Investor Composition

Dec 22
What You Need To Know About PYC Therapeutics Limited's (ASX:PYC) Investor Composition

We Think PYC Therapeutics (ASX:PYC) Can Easily Afford To Drive Business Growth

Nov 17
We Think PYC Therapeutics (ASX:PYC) Can Easily Afford To Drive Business Growth

Financial Position Analysis

Short Term Liabilities: PYC's short term assets (A$85.6M) exceed its short term liabilities (A$9.1M).

Long Term Liabilities: PYC's short term assets (A$85.6M) exceed its long term liabilities (A$1.1M).


Debt to Equity History and Analysis

Debt Level: PYC is debt free.

Reducing Debt: PYC has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: PYC has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: PYC has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 33.2% each year.


Discover healthy companies